Choline-containing compounds
|
Basic information |
| Metabolite name | Choline-containing compounds |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | NA |
| No. of studies | 28 |
|
Basic information |
| Metabolite name | Choline-containing compounds |
| N/A |
|
N/A |
|
N/A |
| Synonyms | NA |
| No. of studies | 28 |
|
Relationship between Choline-containing compounds and depression (count: 28) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1058 | Type1 | depression group vs. control group | Dorsal thalamus | Human | Down |
| Study M1080 | Type2 | non-refractory depression group, post 3-week treatment vs. baseline | Hippocampus | Human | Up |
| Study M1080 | Type4 | non-refractory depression group vs. refractory depression group, post 3-week treatment | Hippocampus | Human | Up |
| Study M219 | Type1 | depression group vs. control group | Hippocampus | Human | Down |
| Study M219 | Type2 | ECT-treated group post-treatment vs. baseline | Hippocampus | Human | Up |
| Study M221 | Type1 | stress group vs. control group | Brain | Tree shrew | Down |
| Study M224 | Type1 | depression group vs. control group | Dorsolateral prefrontal cortex | Human | Up |
| Study M243 | Type1 | depression group vs. control group | Dorsolateral prefrontal cortex | Human | Down |
| Study M246 | Type1 | stress group vs. control group | Brain | Tree shrew | Down |
| Study M252 | Type1 | depression group vs. control group | Putamen | Human | Up |
| Study M252 | Type1 | depression group vs. control group | Hippocampus | Human | Down |
| Study M253 | Type1 | depression group vs. control group | Caudate | Human | Up |
| Study M255 | Type1 | depression group vs. control group | Anterior cingulate cortex | Human | Up |
| Study M256 | Type2 | rTMS-treated responder group post-treatment vs. pre-treatment | Dorsolateral prefrontal cortex | Human | Up |
| Study M256 | Type4 | rTMS-treated responder group vs. non-responder group at baseline | Dorsolateral prefrontal cortex | Human | Down |
| Study M262 | Type1 | stress group vs. control group | Brain | Tree shrew | Down |
| Study M269 | Type1 | multiple episode group vs. control for multiple episode group | Hippocampus | Human | Up |
| Study M271 | Type1 | depression group vs. control group | Thalamus | Human | Down |
| Study M278 | Type1 | depression group vs. control group | Anterior cingulate | Human | Down |
| Study M287 | Type1 | chronic depression group vs. control group | Ventromedial prefrontal cortex | Human | Up |
| Study M292 | Type2 | cLH + ECS group vs. cLH group | Hippocampus | Sprague-Dawley rat | Up |
| Study M305 | Type1 | chronic depression group vs. control group | Hippocampus | Human | Up |
| Study M311 | Type1 | OSAHS group vs. control group | Frontal white matter | Human | Down |
| Study M325 | Type1 | depression group vs. control group | Posterior cingulate cortex | Human | Down |
| Study M329 | Type1 | depression group vs. control group | Dorsolateral prefrontal cortex | Human | Up |
| Study M355 | Type1 | stress group vs. control group | Brain | Tree shrew | Down |
| Study M355 | Type2 | stress + clomipramine group vs. stress group | Brain | Tree shrew | Up |
| Study M355 | Type2 | stress + L-760,735 group vs. stress group | Brain | Tree shrew | Up |
| Study M359 | Type2 | ECT-treated depression group post-treatment vs. pre-treatment | Anterior cingulate cortex | Human | Up |
| Study M485 | Type1 | depression group vs. control group | Hippocampus | Human | Up |
| Study M491 | Type1 | post-CFSS vs. pre-CFSS | Prefrontal cortex | Wistar rat | Up |
| Study M620 | Type1 | MDD group vs. control group | Frontal lobe | Human | Down |
| Study M620 | Type1 | MDD group vs. control group | Parietal lobe | Human | Down |
| Study M643 | Type2 | fish oil group vs. placebo group | Anterior cingulate cortex | Human | Down |
| Study M797 | Type4 | remitter group change values vs. non-remitter group change values | Anterior cingulate cortex | Human | Up |